
How does the data from EHA/ASCO change clinical practice in multiple myeloma?
Agenda
- Introduction - Jon Ukropec & Martin Vogel
- What’s new in AL Amyloidosis & Update on data regarding management of newly diagnosed MM - Shaji Kumar
- Discussion - All - moderated by Jon Ukropec
- Update on data in patients at first relapse - Shaji Kumar
- Discussion - All - moderated by Jon Ukropec
- Highlights relating to management of patients with relapsed/refractory MM - Maria Victoria Mateos
- Discussion - All - moderated by Martin Vogel
- Close - Martin Vogel
- Maria Victoria Mateos (Spain)
- Shaji Kumar (USA)
- Jon Ukropec, GMAL
- Martin Vogel, GMAL